Hidden in Heart Failure

European Cardiology
Douglas Ewan CanniePerry Mark Elliott

Abstract

Current diagnostic strategies fail to illuminate the presence of rare disease in the heart failure population. One-third of heart failure patients are categorised as suffering an idiopathic dilated cardiomyopathy, while others are labelled only as heart failure with preserved ejection fraction. Those affected frequently suffer from delays in diagnosis, which can have a significant impact on quality of life and prognosis. Traditional rhetoric argues that delineation of this patient population is superfluous to treatment, as elucidation of aetiology will not lead to a deviation from standard management protocols. This article emphasises the importance of identifying genetic, inflammatory and infiltrative causes of heart failure to enable patients to access tailored management strategies.

References

Mar 1, 1991·American Heart Journal·N S Peters, P A Poole-Wilson
Jun 1, 1986·Postgraduate Medical Journal·M E Billingham, H D Tazelaar
Jan 1, 1987·American Heart Journal·J RiversA Murphy
Jan 1, 1983·Epidemiologic Reviews·E A Bresnitz, B L Strom
Oct 1, 1983·The American Journal of Cardiology·J Candell-RieraJ Soler-Soler
Aug 3, 1995·The New England Journal of Medicine·S NakaoH Sakuraba
Sep 1, 1993·Circulation·D T KremastinosP K Toutouzas
Jan 13, 1998·Journal of the American College of Cardiology·E GrünigH A Katus
Sep 29, 2001·BMJ : British Medical Journal·L BlueC E Morrison
Dec 6, 2001·American Journal of Respiratory and Critical Care Medicine·R P BaughmanUNKNOWN Case Control Etiologic Study of Sarcoidosis (ACCESS) research group
Jan 12, 2002·European Heart Journal·G HahalisN C Zoumbos
Dec 3, 2003·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Lawreen Heller ConnorsCatherine E Costello
Mar 18, 2004·European Journal of Clinical Investigation·A MehtaM Beck
Sep 7, 2004·American Journal of Respiratory and Critical Care Medicine·Lee S NewmanUNKNOWN ACCESS Research Group
Apr 6, 2005·Journal of the American College of Cardiology·Emily L Burkett, Ray E Hershberger
May 17, 2005·Journal of the American College of Cardiology·Jan-Peter SmedemaHarry J G M Crijns
Sep 21, 2005·Circulation·Uwe KühlHeinz-Peter Schultheiss
Dec 7, 2005·Circulation·Karen SliwaBongani M Mayosi
Feb 8, 2008·Congestive Heart Failure·Gretchen L Wells, William C Little
Sep 11, 2008·Autoimmunity·Alida L P CaforioSabino Iliceto
Sep 27, 2008·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Bernadette ModellDudley J Pennell
May 29, 2009·Journal of Medical Genetics·A MehtaUNKNOWN FOS Investigators
Feb 27, 2010·Current Opinion in Cardiology·Lisa Dellefave, Elizabeth M McNally
Feb 27, 2010·American Journal of Medical Genetics. Part a·Jolien S RuiterJ Peter van Tintelen
May 21, 2010·Circulation. Heart Failure·Dimitrios T KremastinosAndre Keren
Jun 8, 2010·European Journal of Heart Failure·Michele MorettiGianfranco Sinagra
May 21, 2011·Journal of the American College of Cardiology·William P McNairUNKNOWN Familial Cardiomyopathy Registry Research Group
Aug 2, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·David G WarnockUNKNOWN Fabry Registry
Oct 4, 2011·Heart, Lung & Circulation·Pierre-Yves CourandEric Bonnefoy

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
X-ray
enzyme replacement therapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Italian Heart Journal : Official Journal of the Italian Federation of Cardiology
Maria FrigerioDavide Resta
Journal of the American Veterinary Medical Association
Jose C EstepaEscolastico Aguilera-Tejero
International Journal of Obstetric Anesthesia
A T Dennis, J M Castro
Revue médicale suisse
Sarah HugelshoferPierre Monney
© 2021 Meta ULC. All rights reserved